ICECURE MEDICAL LTD (ICCM) Stock Earnings Estimates
NASDAQ:ICCM • IL0011224156
0.6361 USD
+0.06 (+10.09%)
Last: Mar 2, 2026, 03:46 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.09M -25.36% | 3.229M 4.50% | 3.291M 1.92% | 3.945M 19.87% | 5.183M 31.38% | 30.442M 487.34% | 68.463M 124.90% | 88.607M 29.42% | 109.11M 23.14% | 124.87M 14.44% | 134.95M 8.07% | 143.15M 6.08% | |
| EBITDA YoY % growth | -16.49M -71.95% | -15.253M 7.50% | -15.364M -0.73% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -16.74M -72.22% | -15.576M 6.95% | -15.696M -0.77% | -13.935M 11.22% | -11.259M 19.20% | -5.928M 47.35% | 7.943M 233.99% | 19.143M 141.00% | 25.095M 31.09% | 29.97M 19.43% | 33.738M 12.57% | 37.22M 10.32% | |
| Operating Margin | -541.75% | -482.38% | -476.94% | -353.24% | -217.23% | -19.47% | 11.60% | 21.60% | 23.00% | 24.00% | 25.00% | 26.00% | |
| EPS YoY % growth | N/A -54.31% | -0.31 31.65% | -0.30 3.85% | -0.22 26.90% | -0.15 32.56% | -0.07 51.72% | 0.11 257.14% | 0.27 136.36% | 0.35 30.77% | 0.42 20.59% | 0.35 -17.07% | 0.38 8.82% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.05 42.63% | -0.05 15.00% | -0.05 23.50% | -0.03 49.00% | -0.03 44.44% |
| Revenue Q2Q % growth | 1.938M 121.49% | 924.12K 27.46% | 1.026M 95.43% | 1.259M 48.12% | 1.974M 1.86% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.844M 15.04% | -4.275M -16.89% | -4.343M -28.31% | -4.437M -15.67% | -4.3M -11.86% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.06 25.00% | -0.05 | -0.01 | -17.65% |
| Q2 2025 Q2Q % growth | -0.06 | -0.07 | 0.01 | 9.50% |
| Q1 2025 Q2Q % growth | -0.06 25.00% | -0.08 | 0.02 | 26.47% |
| Q4 2024 Q2Q % growth | -0.08 -23.08% | -0.08 | 0.00 | -4.58% |
| Q3 2024 Q2Q % growth | -0.08 8.05% | -0.08 | 0.00 | -4.58% |
| Q2 2024 Q2Q % growth | -0.06 25.00% | -0.07 | 0.01 | 15.97% |
| Q1 2024 Q2Q % growth | -0.08 | -0.08 | 0.00 | 1.96% |
| Q4 2023 Q2Q % growth | -0.07 40.91% | -0.07 | 0.01 | 8.96% |
| Q3 2023 Q2Q % growth | -0.09 20.91% | -0.09 | 0.00 | 5.23% |
| Q2 2023 Q2Q % growth | -0.08 33.33% | -0.09 | 0.01 | 9.51% |
| Q1 2023 Q2Q % growth | -0.08 | -0.10 | 0.02 | 15.96% |
| Q4 2022 Q2Q % growth | -0.11 | -0.11 | 0.00 | -4.37% |
| Q3 2022 Q2Q % growth | -0.11 | -0.12 | 0.01 | 6.22% |
| Q2 2022 Q2Q % growth | -0.12 | -0.12 | 0.00 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 850K 28.40% | 728.28K | 121.72K | 16.71% |
| Q2 2025 Q2Q % growth | 525K -48.07% | 675.75K | -150.75K | -22.31% |
| Q1 2025 Q2Q % growth | 725K -2.42% | 765K | -40K | -5.23% |
| Q4 2024 Q2Q % growth | 875K -30.28% | 1.089M | -214K | -19.65% |
| Q3 2024 Q2Q % growth | 662K 106.88% | 722.67K | -60.67K | -8.40% |
| Q2 2024 Q2Q % growth | 1.011M 7.55% | 944.01K | 66.99K | 7.10% |
| Q1 2024 Q2Q % growth | 743K 4.65% | 893.01K | -150.01K | -16.80% |
| Q4 2023 Q2Q % growth | 1.255M 33.51% | 1.19M | 65K | 5.46% |
| Q3 2023 Q2Q % growth | 320K -49.21% | 1.042M | -722K | -69.29% |
| Q2 2023 Q2Q % growth | 940K 22.08% | 959.137K | -19.137K | -2.00% |
| Q1 2023 Q2Q % growth | 710K -5.33% | 983.617K | -273.617K | -27.82% |
| Q4 2022 Q2Q % growth | 940K | 1.016M | -76K | -7.48% |
| Q3 2022 Q2Q % growth | 630K | 936.36K | -306.36K | -32.72% |
| Q2 2022 Q2Q % growth | 770K 20.31% | 838.44K | -68.44K | -8.16% |
| Q1 2022 Q2Q % growth | 750K -47.92% | % | ||
| Q2 2021 Q2Q % growth | 640K -65.03% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0.77% |
| Revenue | 0% | 11.7% | 0% | 16.47% |